Medical Journals

Evaluation of Neurovirulence and Biodistribution of Venezuelan Equine Encephalitis Replicon Particles Expressing Herpes Simplex Virus Type 2 Glycoprotein D.

Authors:
  • Kowalski Jacek
  • Adkins Karissa
  • Gangolli Seema
  • Ren Jian
  • Arendt Heather
  • DeStefano Joanne
  • Obregon Jennifer
  • Tummolo Donna
  • Natuk Robert J
  • Brown Tom P
  • Parks Christopher L
  • Udem Stephen A
  • Long Deborah

From: Vaccine Discovery Department, Wyeth Research, 401 North Middletown Road, Pearl River, NY 10965, USA. kowalsj@wyeth.com

Vaccine

  • Publish Date: Mar 2007
  • ISSN: 0264-410X
  • Volume: 25
  • Issue: 12
  • Pages: 2296-305
  • Medium: Print
  • Language: English
  • Citation (JAMA): Kowalski Jacek, Adkins Karissa, Gangolli Seema, et al. Evaluation of Neurovirulence and Biodistribution of Venezuelan Equine Encephalitis Replicon Particles Expressing Herpes Simplex Virus Type 2 Glycoprotein D.. Vaccine Mar 2007;25:2296-305

Abstract

The safety of a propagation-defective Venezuelan equine encephalitis virus (VEEV) replicon particle vaccine was examined in mice. After intracranial inoculation we observed approximately 5% body weight loss, modest inflammatory changes in the brain, genome replication, and foreign gene expression. These changes were transient and significantly less severe than those caused by TC-83, a live-attenuated vaccinal strain of VEEV that has been safely used to immunize military personnel and laboratory workers. Replicon particles injected intramuscularly or intravenously were detected at limited sites 3 days post-administration, and were undetectable by day 22. There was no evidence of dissemination to spinal cord or brain after systemic administration. These results demonstrate that propagation-defective VEEV replicon particles are minimally neurovirulent and lack neuroinvasive potential.

Mesh Headings (Keywords): Animals, Body Weight, Brain, Encephalitis Virus, Venezuelan Equine, Encephalomyelitis, Venezuelan Equine, Injections, Intramuscular, Injections, Intravenous, Mice, RNA, Viral, Replicon, Reverse Transcriptase Polymerase Chain Reaction, Spinal Cord, Vaccines, Attenuated, Viral Envelope Proteins, Virus Replication


Check for Full Text / PubMed Unique Identifier (PMID): 17239997


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.